SCHEMBL9681647

SCHEMBL9681647

CCCC(O)OC(=O)CC(C)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 2/20 0.44
GAA P10253 2/20 0.44
SI P14410 2/20 0.44
MGAM2 Q2M2H8 2/20 0.44
HDAC7 Q8WUI4 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
HDAC9 Q9UKV0 1/20 0.34
HDAC5 Q9UQL6 1/20 0.34
FAAH O00519 4/20 0.34
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34
TDP1 Q9NUW8 2/20 0.33
CHRM1 P11229 1/20 0.33
AKR1A1 P14550 1/20 0.33
CHRM3 P20309 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
ADRA1A P35348 1/20 0.33
HRH1 P35367 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9680472 0.88 MGAM (0.41) MGAMGAASIMGAM2FAAH
SCHEMBL9318303 0.83 MGAM (0.44) MGAMGAASIMGAM2
SCHEMBL3909146 0.83 MGAM (0.48) MGAMGAASIMGAM2TDP1
SCHEMBL2381597 0.81 MGAM (0.46) MGAMGAASIMGAM2HDAC7
SCHEMBL2706936 0.80 LMNA (0.42) HDAC7HDAC8HDAC6HDAC9HDAC5
SCHEMBL29190726 0.79 FAAH (0.49) MGAMGAASIMGAM2HDAC7
SCHEMBL10430878 0.78 ALDH1A1 (0.48) HDAC8TDP1CHRM1AKR1A1CHRM3
SCHEMBL446905 0.78
SCHEMBL14764391 0.78 TSHR (0.52) TSHRALDH1A1LMNACA2
SCHEMBL28002469 0.78 MGAM (0.43) MGAMGAASIMGAM2HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12577591-B2 Microorganisms and methods for increasing co-factors GENOMATICA, INC. (US) 2026-03-17 US claimed
US-20240150798-A1 MICROORGANISMS AND METHODS FOR PRODUCING (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTYRATE GENOMATICA INC (US) 2024-05-09 US claimed
US-11814664-B2 Microorganisms and methods for producing (3R)-hydroxybutyl (3R)-hydroxybutyrate GENOMATICA, INC. (US) 2023-11-14 US claimed
US-20230285348-A1 COMPOSITIONS AND METHODS FOR WEIGHT LOSS MAINTENANCE UNIVERSITY OF SOUTH FLORIDA 2023-09-14 US claimed
US-20220403420-A1 MICROORGANISMS AND METHODS FOR INCREASING CO-FACTORS AGAIN BIO APS (DK) 2022-12-22 US claimed
EP-4051657-A1 MICROORGANISMS AND METHODS FOR REDUCING BY-PRODUCTS Genomatica, Inc. (US) 2022-09-07 EP claimed
EP-4048781-A1 MICROORGANISMS AND METHODS FOR INCREASING CO-FACTORS Genomatica, Inc. (US) 2022-08-31 EP claimed
CN-114728871-A Microorganisms and methods for reducing by-products 基因组股份公司 2022-07-08 CN claimed
WO-2021086944-A1 MICROORGANISMS AND METHODS FOR RECUCING BY-PRODUCTS GENOMATICA, INC. (US) 2021-05-06 WO claimed
WO-2021081185-A1 MICROORGANISMS AND METHODS FOR INCREASING CO-FACTORS GENOMATICA, INC. (US) 2021-04-29 WO claimed
US-20200397736-A1 COMPOSITIONS AND METHODS FOR WEIGHT LOSS MAINTENANCE UNIVERSITY OF SOUTH FLORIDA 2020-12-24 US claimed
EP-3723511-A1 COMPOSITIONS AND METHODS FOR WEIGHT LOSS MAINTENANCE University of South Florida (US) 2020-10-21 EP claimed
WO-2019118624-A1 COMPOSITIONS AND METHODS FOR WEIGHT LOSS MAINTENANCE UNIVERSITY OF SOUTH FLORIDA (US) 2019-06-20 WO claimed
CN-108042516-A Application of R, S-1,3- the butanediol acetoacetate diester in prevention or treatment decompression medicine is prepared 中国人民解放军第二军医大学 2018-05-18 CN claimed
US-20170266147-A1 METHODS OF INCREASING LATENCY OF ANESTHETIC INDUCTION USING KETONE SUPPLEMENTATION NAVY, SECRETARY OF THE UNITED STATES OF AMERICA 2017-09-21 US claimed
US-20160108442-A1 MICROORGANISMS AND METHODS FOR PRODUCING (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTYRATE GENOMATICA, INC. (US) 2016-04-21 US claimed
US-12577591-B2 Microorganisms and methods for increasing co-factors GENOMATICA, INC. (US) 2026-03-17 US disclosed
US-20240150798-A1 MICROORGANISMS AND METHODS FOR PRODUCING (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTYRATE GENOMATICA INC (US) 2024-05-09 US disclosed
US-4997976-A Use of 1,3-butanediol acetoacetate in parenteral oral nutrition BRUNENGRABER HENRI (CA) 1991-03-05 US disclosed
EP-0318357-A2 1,3-Butanediol acetoacetate and its use in parenteral and oral nutrition Brunengraber, Henri (CA) 1989-05-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240150798-A1 MICROORGANISMS AND METHODS FOR PRODUCING (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTYRATE ACACB, GRHPR, HSD17B10 MGAM 208/4885GAA 613/4885SI 343/4885
US-11814664-B2 Microorganisms and methods for producing (3R)-hydroxybutyl (3R)-hydroxybutyrate ACACB, GRHPR, HSD17B10 MGAM 208/4885GAA 613/4885SI 343/4885
US-12577591-B2 Microorganisms and methods for increasing co-factors ABAT, HADHB, MMAB MGAM 407/4885GAA 878/4885SI 2509/4885
US-20160108442-A1 MICROORGANISMS AND METHODS FOR PRODUCING (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTYRATE ACACB, GRHPR, HSD17B10 MGAM 208/4885GAA 613/4885SI 343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.